Stifel Financial Corp Has $9.22 Million Holdings in Align Technology, Inc. (NASDAQ:ALGN)

Stifel Financial Corp decreased its position in shares of Align Technology, Inc. (NASDAQ:ALGNFree Report) by 30.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 33,638 shares of the medical equipment provider’s stock after selling 14,615 shares during the period. Stifel Financial Corp’s holdings in Align Technology were worth $9,217,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Huntington National Bank increased its holdings in Align Technology by 94.9% during the 3rd quarter. Huntington National Bank now owns 115 shares of the medical equipment provider’s stock valued at $35,000 after purchasing an additional 56 shares in the last quarter. Orion Capital Management LLC bought a new position in shares of Align Technology in the third quarter valued at about $61,000. Operose Advisors LLC acquired a new position in Align Technology during the 3rd quarter worth about $63,000. Covestor Ltd grew its holdings in Align Technology by 379.5% during the 3rd quarter. Covestor Ltd now owns 211 shares of the medical equipment provider’s stock worth $64,000 after acquiring an additional 167 shares during the last quarter. Finally, Valley National Advisers Inc. increased its position in Align Technology by 29.7% in the 3rd quarter. Valley National Advisers Inc. now owns 214 shares of the medical equipment provider’s stock valued at $65,000 after acquiring an additional 49 shares in the last quarter. Institutional investors own 88.43% of the company’s stock.

Align Technology Stock Performance

NASDAQ ALGN opened at $256.01 on Thursday. The stock has a market cap of $19.27 billion, a price-to-earnings ratio of 42.18, a PEG ratio of 4.66 and a beta of 1.62. The business has a 50 day simple moving average of $289.25 and a 200 day simple moving average of $279.94. Align Technology, Inc. has a 52-week low of $176.34 and a 52-week high of $413.20.

Align Technology (NASDAQ:ALGNGet Free Report) last issued its quarterly earnings data on Wednesday, April 24th. The medical equipment provider reported $1.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.08. The company had revenue of $997.43 million during the quarter, compared to the consensus estimate of $971.97 million. Align Technology had a net margin of 11.80% and a return on equity of 14.15%. On average, analysts predict that Align Technology, Inc. will post 7.95 EPS for the current year.

Wall Street Analyst Weigh In

Several analysts have recently commented on the stock. Morgan Stanley increased their price target on shares of Align Technology from $344.00 to $360.00 and gave the company an “overweight” rating in a research note on Thursday, April 25th. Piper Sandler reiterated an “overweight” rating and set a $375.00 target price (up previously from $355.00) on shares of Align Technology in a research report on Thursday, April 25th. Robert W. Baird lifted their price objective on Align Technology from $333.00 to $370.00 and gave the stock an “outperform” rating in a research note on Thursday, April 25th. Leerink Partnrs reissued a “market perform” rating on shares of Align Technology in a research note on Monday, February 26th. Finally, SVB Leerink initiated coverage on Align Technology in a research report on Monday, February 26th. They set a “market perform” rating and a $310.00 target price for the company. One analyst has rated the stock with a sell rating, three have given a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $353.00.

Read Our Latest Analysis on Align Technology

About Align Technology

(Free Report)

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.

Featured Stories

Institutional Ownership by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.